E. Garcia-zaragoza et al., Role of central glutamate receptors, nitric oxide and soluble guanylyl cyclase in the inhibition by endotoxin of rat gastric acid secretion, BR J PHARM, 130(6), 2000, pp. 1283-1288
1 This study examines the role of a central pathway involving glutamate rec
eptors, nitric oxide (NO) and cyclic GMP in the acute inhibitory effects of
low doses of peripheral endotoxin on pentagastrin-stimulated acid producti
on.
2 Vagotomy or intracisternal (i.c.) microinjections of the NO-inhibitor, N-
G-nitro-L-arginine methyl esther (L-NAME; 200 mu g rat(-1)) restored acid s
ecretory responses in endotoxin (10 mu g kg(-1), i.v.)-treated rats.
3 The acid-inhibitory effect of i.v. endotoxin (10 mu g kg(-1), i.v.) was p
revented by prior i.c. administration of the NMDA receptor antagonists, diz
ocilpine maleate (MK-801; 10 nmol rat(-1)) and D-2-amino-5-phosphono-valeri
c acid (AP-5; 20 nmol rat(-1)), or the AMPA/kainate antagonist 6,7-dinitroq
uinoxaline-2,3-dione (DNQX; 10 nmol rat(-1)). However, the competitive meta
botropic glutamate receptor antagonist (+)-alpha-methyl-4-carboxyphenylglyc
ine (MCPG; 20-1000 nmol rat(-1)) did not antagonize the effects of endotoxi
n.
4 I.c, administration of L-glutamate (0.1 nmol rat(-1)) inhibited pentagast
rin-stimulated gastric acid secretion. Coadministration with L-NAME (200 mu
g rat(-1)) prevented the inhibition of gastric acid secretion by the amino
acid.
5 I.c. administration of 1H-[1,2,4]Oxazodiolo[4,3-a]quinoxalin-1-one (ODQ;
100 nmol rat(-1)), a soluble guanylyl cyclase (sGC) blocker, reversed the h
yposecretory effect of endotoxin.
6 I.c. administration of the cyclic GMP analogue 8-Bromoguanosine-3,5-cycli
c monophosphate (8Br-cGMP; 100-300 nmol rat(-1)) reduced gastric acid produ
ction in a dose-dependent manner.
7 We conclude that central NMDA and AMPA/kainate receptors are involved in
the acid inhibitory effect of peripherally administered endotoxin. This cen
tral pathway involves synthesis of NO, which acts on the enzyme sGC.